A Study of Evacetrapib and Rifampin in Healthy Participants

Clinical trial NCT01908582 · COMPLETED

Trial details

NCT number: NCT01908582
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2013-07-01
Primary completion: 2013-09-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.